Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.60 |
| ▸ | CA2 | P00918 | 2/20 | 0.60 |
| ▸ | MMP1 | P03956 | 1/20 | 0.60 |
| ▸ | MMP2 | P08253 | 1/20 | 0.60 |
| ▸ | MMP9 | P14780 | 1/20 | 0.60 |
| ▸ | MMP8 | P22894 | 1/20 | 0.60 |
| ▸ | MMP13 | P45452 | 1/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | F2 | P00734 | 3/20 | 0.55 |
| ▸ | PRSS1 | P07477 | 3/20 | 0.55 |
| ▸ | PRSS2 | P07478 | 3/20 | 0.55 |
| ▸ | PRSS3 | P35030 | 3/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.54 |
| ▸ | CA12 | O43570 | 7/20 | 0.51 |
| ▸ | CA9 | Q16790 | 7/20 | 0.51 |
| ▸ | FABP3 | P05413 | 1/20 | 0.51 |
| ▸ | FABP4 | P15090 | 1/20 | 0.51 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3893485 | 0.98 | CA1 (0.58) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL7917646 | 0.84 | CA1 (0.42) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL3645882 | 0.83 | ALDH1A1 (0.48) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL30444901 | 0.82 | CA1 (0.64) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL989207 | 0.82 | CA1 (0.64) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL11348903 | 0.82 | CA1 (0.64) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL7022695 | 0.82 | AKR1C3 (0.53) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL6153587 | 0.82 | TSHR (0.57) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL29443910 | 0.82 | ALOX15 (0.46) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL7899541 | 0.82 | ALOX15 (0.46) | CA1CA2MMP1MMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 443 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024163315-A2 | DERIVATIZED COLLAGEN-HYALURONIC ACID BASED IMPLANTS FOR SUSTAINED DELIVERY OF OPHTHALMIC DRUGS | DEVORE DALE (US) | 2024-08-08 | — | — | WO | claimed |
| US-20240252446-A1 | DERIVATIZED COLLAGEN-HYALURONIC ACID BASED IMPLANTS FOR SUSTAINED DELIVERY OF OPHTHALMIC DRUGS | SUSTAINED DRUG DELIVERY LLC | 2024-08-01 | — | — | US | claimed |
| US-20210386906-A1 | METHODS AND FORMULATIONS FOR TRANSDERMAL ADMINISTRATION OF DERMAL CONTOURING AGENTS | DYVE BIOSCIENCES, INC. (US) | 2021-12-16 | — | — | US | claimed |
| US-20180153787-A1 | METHODS AND ARTICLES OF MANUFACTURE FOR THE TREATMENT OF SKIN | Advanced Collagen Science LLC | 2018-06-07 | — | — | US | claimed |
| CN-106832783-A | A kind of method of the toughening modifying of epoxy resin | 中冶建筑研究总院有限公司 | 2017-06-13 | — | — | CN | claimed |
| US-20160038391-A1 | METHODS AND ARTICLES OF MANUFACTURE FOR THE TREATMENT OF SKIN | Advanced Collagen Science LLC (US) | 2016-02-11 | — | — | US | claimed |
| EP-2981324-A2 | METHODS AND ARTICLES OF MANUFACTURE FOR THE TREATMENT OF SKIN | Miller, Leonard B. (US) | 2016-02-10 | — | — | EP | claimed |
| CN-103613521-B | The water phase synthesis method of probenecid | CHEMICAL INST., SHANDONG PROV. (CN) | 2015-10-21 | — | — | CN | claimed |
| CN-104693075-A | p18 small-molecule inhibitor and application thereof in human hematopoietic stem cell in-vitro amplification | CHENG TAO | 2015-06-10 | — | — | CN | claimed |
| WO-2014165741-A2 | METHODS AND ARTICLES OF MANUFACTURE FOR THE TREATMENT OF SKIN | MILLER LEONARD B (US) | 2014-10-09 | — | — | WO | claimed |
| EP-0212741-B1 | A PROCESS FOR THE PREPARATION OF AN AZIDOSULPHONYLBENZOIC ACID | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1989-12-06 | — | — | EP | claimed |
| US-4666631-A | Process for the preparation of an azidosulphonylbenzoic acid | SHELL OIL COMPANY (US) | 1987-05-19 | — | — | US | claimed |
| EP-0212741-A1 | A process for the preparation of an azidosulphonylbenzoic acid | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1987-03-04 | — | — | EP | claimed |
| JP-57212154-A | — | — | None | — | — | JP | disclosed |
| US-20260076824-A1 | BAFFLE DEVICES AND RELATED METHODS FOR DELIVERY OF THERAPEUTIC COMPOSITIONS TO THE EYE | D&D BIOPHARMACEUTICALS, LLC (US) | 2026-03-19 | — | — | US | disclosed |
| EP-4626372-A1 | DEVICES AND METHODS FOR CORNEA TREATMENT | D&D Biopharmaceuticals, LLC (US) | 2025-10-08 | — | — | EP | disclosed |
| EP-0212741-A1 | A process for the preparation of an azidosulphonylbenzoic acid | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1987-03-04 | — | — | EP | disclosed |
| EP-0068407-A1 | Aminosulfonylbenzoic acid derivatives | HODOGAYA CHEMICAL CO., LTD. (JP) | 1983-01-05 | — | — | EP | disclosed |
| JP-S57212154-A | NOVEL AMINOSULFONYLBENZOIC ACID DERIVATIVE | HODOGAYA CHEM CO LTD | 1982-12-27 | — | — | JP | disclosed |
| US-4346088-A | ANTILIPEMICS | HOECHST AKTIENGESELLSCHAFT (DE) | 1982-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260076824-A1 | BAFFLE DEVICES AND RELATED METHODS FOR DELIVERY OF THERAPEUTIC COMPOSITIONS TO THE EYE | VEGFA, IL17A, IL15 | CA1 4319/4885CA2 3716/4885MMP1 278/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.